Following the rerating, Danaher shares seem to have found their footing, with downward [earnings] estimate revisions ...

As previously reported, Stifel analyst Daniel Arias upgraded Danaher (DHR) to Buy from Hold with an unchanged price target of $260, telling ...

Stifel upgraded Danaher (DHR) to Buy from Hold with a $260 price target Light Up your Portfolio with Spark:Easily identify stocks' risks and ...

The Rising Need for Efficient and Effective Drug Discoveries Worldwide is Expected to Create Lucrative Growth Opportunities in the Market.

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

Banco Santander increased its stake in Danaher by 56.2%, now holding 8,757 shares worth $2.01 million. Several other ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...

Why Is Danaher Corporation’s Stock Showing Market Fluctuations?

Diamond Hill Small Cap Strategy portfolio outperformed the Russell 2000 Index in Q4 and for the full year. Click here to read ...

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” fourth quarter 2024 investor letter ...